#Japan #Tokyo #Biopharma #global brand #Ajinomoto Bio-Pharma

Ajinomoto Bio-Pharma Services Unveils Refreshed Global Brand

Ajinomoto Bio-Pharma Services, often referred to as Aji Bio-Pharma, has taken a significant step forward by unveiling its revitalized global brand. This strategic move highlights the organization’s commitment to specialization in the field of contract development and manufacturing services. The updated brand identity reflects the company’s depth of expertise, positioning it as a reliable partner for biopharmaceutical companies facing challenging development and manufacturing environments.

On October 5, 2026, the company launched the new brand, which includes updated messaging, a redesigned visual identity, and a revamped global website. These changes are intended to clearly communicate Aji Bio-Pharma's mission and dedication to advancing healthcare solutions. The company aims to support customers effectively as they work to develop innovative medicines that enhance human health.

In the current landscape of the biopharmaceutical industry, companies increasingly require profound knowledge and specialized services to navigate complex development challenges. Aji Bio-Pharma’s strength lies in its focus on various biopharmaceutical modalities, including small molecules, oligonucleotides, peptides, gene therapy, proteins, and bioconjugates. By maintaining a dedicated focus on these distinct areas, Aji Bio-Pharma pairs its specialization with scientific innovation, enabling the organization to provide tailored solutions to its clients.

The roots of Aji Bio-Pharma stretch back to the Ajinomoto Group's over century-long legacy of scientific innovation. This rich history has fostered the development of proprietary technologies that pave the way for new possibilities in biopharma development and manufacturing. With a steadfast commitment to quality, operational excellence, and sustainability, Aji Bio-Pharma ensures that customers can rely on their expertise to enhance their product offerings and programs.

According to Yasuyuki Otake, Corporate Executive and General Manager of the Bio-Pharma Services Department at Ajinomoto Co., Inc., the new brand identity at Aji Bio-Pharma centers on the organization’s robust capabilities.